MetaCen Therapeutics Co. Ltd.
- Biotech or pharma, therapeutic R&D
MetaCen Therapeutics (MCT) specializes in the development of therapeutically effective nutraceuticals and pharmaceuticals targeting metabolic diseases. Its core focus lies in Advanced Glycation End-products (AGEs), which are recognized as key disruptors in metabolic dysfunction.
Leveraging its proprietary Metabolism Targeting & Balancing (MTB) framework, MCT identifies and modulates critical metabolic factors and toxins to restore metabolic balance, promote recovery, and prevent disease progression.
MCT has successfully completed proof-of-concept (PoC) validation for its approach through tens of thousands of case studies and numerous human trials conducted at over 1,000 pharmacies and clinics nationwide.
Address
SuwonGyeonggi-do
South Korea
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}